13F Holdings
中文EN

MCK MCKESSON CORP

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 927653 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.2%
TTM net income YoY16.5%
TTM EPS YoY21.1%
Revenue 3-yr CAGR12.9%
Net income 3-yr CAGR10.5%

Margins

Gross margin3.7%
Operating margin1.6%
Net margin1.1%
FCF margin1.7%
EBITDA margin1.7%

Returns

ROE—
ROA5.3%
ROIC (approx.)1,481.2%
Asset turnover4.75x

Leverage & solvency

Liabilities / assets101.1%
Debt / equity—
Current ratio0.90x
Interest coverage21.87x

Cash quality & payout

Operating cash flow / net income1.60x
Accruals ratio-3.2%
Payout ratio8.5%
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31FY20242024-03-31FY20232023-03-31FY20222022-03-31
Income statement
Revenue$403.43B$359.05B$308.95B$276.71B$263.97B
Cost of revenue$388.88B$345.73B$296.12B$264.35B$250.84B
Gross profit$14.55B$13.32B$12.83B$12.36B$13.13B
SG&A expense$8.10B$8.51B$8.66B$7.78B$10.54B
Operating income$6.21B$4.42B$3.91B$4.38B$2.04B
Interest expense$247.00M$265.00M$252.00M$248.00M$178.00M
Pretax income$6.20B$4.36B$3.79B$4.63B$1.93B
Income tax$1.10B$878.00M$629.00M$905.00M$636.00M
Net income$4.76B$3.29B$3.00B$3.56B$1.11B
EBITDA$6.50B$4.69B$4.19B$4.65B$2.35B
EPS (basic)38.5525.8622.5425.237.32
EPS (diluted)38.3825.7222.3925.037.23
Dividends declared per share3.172.752.402.091.83
Weighted avg. shares (diluted)124.10M128.10M134.10M142.20M154.10M
Balance sheet
Cash & equivalents$3.98B$5.96B$4.58B$4.68B$3.94B
Receivables$27.98B$25.64B$21.62B$19.41B$18.58B
Inventory$24.21B$23.00B$21.14B$19.69B$18.70B
Current assets$57.21B$55.40B$47.97B$44.29B$46.23B
PP&E, net$2.67B$2.50B$2.32B$2.18B$2.09B
Goodwill$11.32B$10.02B$10.13B$9.95B$9.45B
Intangibles$4.08B$1.46B$2.11B$2.28B$2.06B
Total assets$82.32B$75.14B$67.44B$62.32B$63.30B
Current liabilities$67.02B$61.60B$52.36B$47.96B$48.47B
Short-term debt$1.27B$1.19B$50.00M$968.00M$799.00M
Long-term debt$5.26B$4.46B$5.58B$4.63B$5.08B
Total debt$6.53B$5.65B$5.63B$5.59B$5.88B
Total liabilities$83.16B$76.83B$69.04B$63.81B$65.09B
Shareholders' equity-$2.17B-$2.07B-$1.97B-$1.86B-$2.27B
Net debt$2.55B-$302.00M$1.05B$915.00M$1.94B
Cash flow statement
Operating cash flow$6.16B$6.08B$4.31B$5.16B$4.43B
Capital expenditure$436.00M$537.00M$431.00M$390.00M$388.00M
Free cash flow$5.72B$5.55B$3.88B$4.77B$4.05B
Investing cash flow-$3.43B-$733.00M-$1.07B-$542.00M-$89.00M
Financing cash flow-$4.63B-$3.96B-$3.34B-$4.37B-$6.32B
Depreciation & amortization$287.00M$272.00M$279.00M$272.00M$312.00M
Stock-based compensation$247.00M$226.00M$182.00M$162.00M$161.00M
Dividends paid$381.00M$345.00M$314.00M$292.00M$277.00M
Share buybacks$4.75B$3.15B$3.02B$3.64B$3.52B

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.